Barclays analyst Geoff Meacham maintained a Hold rating on AbbVie (ABBV) yesterday and set a price target of $86. The company’s shares closed yesterday at $80.79, close to its 52-week low of $75.77.
According to TipRanks.com, Meacham is a 4-star analyst with an average return of 4.7% and a 53.3% success rate. Meacham covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Vertex Pharmaceuticals, and Johnson & Johnson.
AbbVie has an analyst consensus of Hold, with a price target consensus of $93.
See today’s analyst top recommended stocks >>
AbbVie’s market cap is currently $121.5B and has a P/E ratio of 22.51. The company has a Price to Book ratio of -41.60.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
